/PRNewswire/ PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023. Second quarter results Revenue of $47.6 million, a.
New York, NY (PRWEB) August 01, 2023 New York, NY (July 31, 2023) Psychosocial stress profoundly affects people’s lives globally, not least because it can
PacBio, a leading developer of high-quality, highly accurate sequencing solutions today announced a clinical research study with Radboud University Medical Center (Radboudumc) to explore genetic causes of rare and genetic diseases.
/PRNewswire/ PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions today announced a clinical research study with.